McKesson Corp. (MCK): Price and Financial Metrics

McKesson Corp. (MCK): $369.03

2.07 (+0.56%)

POWR Rating

Component Grades














  • MCK scores best on the Growth dimension, with a Growth rank ahead of 98.36% of US stocks.
  • MCK's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • MCK ranks lowest in Momentum; there it ranks in the 43rd percentile.

MCK Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for MCK is -133.96 -- better than only 0.07% of US stocks.
  • MCK's price/sales ratio is 0.19; that's higher than the P/S ratio of merely 4.02% of US stocks.
  • MCK's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 0.47% of US stocks.
  • Stocks that are quantitatively similar to MCK, based on their financial statements, market capitalization, and price volatility, are STCN, PBPB, JILL, LYV, and ORLY.
  • Visit MCK's SEC page to see the company's official filings. To visit the company's web site, go to

MCK Valuation Summary

  • MCK's EV/EBIT ratio is 24.2; this is 124.07% higher than that of the median Healthcare stock.
  • Over the past 243 months, MCK's price/earnings ratio has gone up 15.9.

Below are key valuation metrics over time for MCK.

Stock Date P/S P/B P/E EV/EBIT
MCK 2022-09-01 0.2 -26.1 37.5 24.2
MCK 2022-08-31 0.2 -26.3 37.8 24.4
MCK 2022-08-30 0.2 -26.1 37.5 24.2
MCK 2022-08-29 0.2 -26.0 37.4 24.1
MCK 2022-08-26 0.2 -25.6 36.7 23.7
MCK 2022-08-25 0.2 -26.3 37.8 24.4

MCK Growth Metrics

    Its 3 year price growth rate is now at 158.47%.
  • Its 3 year revenue growth rate is now at 23.17%.
  • Its 4 year cash and equivalents growth rate is now at -26.52%.
MCK's revenue has moved up $4.6465e+10 over the prior 33 months.

The table below shows MCK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 268,446 5,115 1,396
2022-03-31 263,966 4,434 1,114
2021-12-31 257,006 4,917 1,412
2021-09-30 250,991 4,753 -4,807
2021-06-30 245,223 3,982 -4,497
2021-03-31 238,228 4,542 -4,539

MCK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MCK has a Quality Grade of C, ranking ahead of 60.07% of graded US stocks.
  • MCK's asset turnover comes in at 3.903 -- ranking 8th of 105 Wholesale stocks.
  • DPZ, SPRS, and ENS are the stocks whose asset turnover ratios are most correlated with MCK.

The table below shows MCK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 3.903 0.051 -0.395
2021-03-31 3.872 0.051 -0.391
2020-12-31 3.922 0.051 -0.378
2020-09-30 3.881 0.052 0.202
2020-06-30 3.870 0.052 0.079
2020-03-31 3.807 0.052 0.071

MCK Price Target

For more insight on analysts targets of MCK, see our MCK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $240.39 Average Broker Recommendation 1.47 (Moderate Buy)

MCK Stock Price Chart Interactive Chart >

Price chart for MCK

MCK Price/Volume Stats

Current price $369.03 52-week high $375.23
Prev. close $366.96 52-week low $193.89
Day low $366.13 Volume 217,240
Day high $369.37 Avg. volume 1,126,662
50-day MA $346.35 Dividend yield 0.59%
200-day MA $299.17 Market Cap 53.04B

McKesson Corp. (MCK) Company Bio

McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 78,000 employees. McKesson had revenues of $238.2 billion in its fiscal year ending March 31, 2021. (Source:Wikipedia)

MCK Latest News Stream

Event/Time News Detail
Loading, please wait...

MCK Latest Social Stream

Loading social stream, please wait...

View Full MCK Social Stream

Latest MCK News From Around the Web

Below are the latest news stories about MCKESSON CORP that investors may wish to consider to help them evaluate MCK as an investment opportunity.

Chemed's (CHE) Roto-Rooter Growth Aids, Macro Challenges Ail

Chemed's (CHE) VITAS segment revenue decline during the second quarter gets somewhat offset by a geographically weighted average Medicare reimbursement rate increase of nearly 1.3%.

Yahoo | September 2, 2022

Here's Why You Should Retain Haemonetics (HAE) Stock Now

Investors are optimistic about Haemonetics' (HAE) better-than-expected results and strong Plasma sales.

Yahoo | September 2, 2022

Haemonetics (HAE) Business Recovery Continues, Macro Issues Ail

Despite sluggish results of Haemonetics' (HAE) Blood Center business, Whole Blood revenues grow on favorable order timing among distributors in the Asia Pacific and EMEA.

Yahoo | September 2, 2022

McKesson (MCK) Up 7.7% Since Last Earnings Report: Can It Continue?

McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 2, 2022

Nevro's (NVRO) PDN Therapy Gets Positive Coverage Updates

Latest favorable coverage decisions for Nevro's (NVRO) PDN Therapy are expected to serve a wider patient pool.

Yahoo | September 2, 2022

Read More 'MCK' Stories Here

MCK Price Returns

1-mo 4.17%
3-mo 17.95%
6-mo 31.60%
1-year 80.20%
3-year 163.66%
5-year 146.98%
YTD 49.15%
2021 44.23%
2020 27.06%
2019 26.72%
2018 -28.40%
2017 11.95%

MCK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MCK Dividend History

Continue Researching MCK

Here are a few links from around the web to help you further your research on Mckesson Corp's stock as an investment opportunity:

Mckesson Corp (MCK) Stock Price | Nasdaq
Mckesson Corp (MCK) Stock Quote, History and News - Yahoo Finance
Mckesson Corp (MCK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.613 seconds.